Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Herpes simplex virus (type 1 / strain 17) | Alpha trans-inducing protein (VP16) | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | nuclear receptor subfamily 2, group E, member 3 | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Nuclear hormone receptor family member nhr-49 | nuclear receptor subfamily 2, group E, member 3 | 410 aa | 384 aa | 28.1 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0286 | 0.2832 | 1 | |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0071 | 0.0071 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.0359 | 0.1218 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0445 | 0.151 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.052 | 0.1765 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0071 | 0.024 |
Onchocerca volvulus | 0.0036 | 0.0247 | 0.0871 | |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1365 | 0.4629 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.052 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0071 | 0.0071 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0323 | 0.6209 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0247 | 0.0247 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.0359 | 0.6903 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0323 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0323 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0071 | 0.136 |
Onchocerca volvulus | 0.006 | 0.0491 | 0.1735 | |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0299 | 0.5753 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0496 | 0.1684 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1365 | 0.4629 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0071 | 0.0173 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0071 | 0.0173 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0299 | 0.1015 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0071 | 0.024 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.052 | 0.1765 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0297 | 0.2948 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2473 | 0.8388 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0247 | 0.4739 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0071 | 0.0173 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0445 | 0.1087 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0071 | 0.0071 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.052 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0233 | 0.0569 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0496 | 0.1684 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0445 | 0.0445 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0247 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.023 | 0.2253 | 0.2253 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0496 | 0.1684 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0323 | 0.6209 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0247 | 0.4739 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0247 | 0.0602 |
Onchocerca volvulus | 0.0047 | 0.0359 | 0.1268 | |
Brugia malayi | hypothetical protein | 0.0043 | 0.0323 | 0.1096 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.2253 | 0.7644 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.0359 | 0.6903 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.052 | 0.1765 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0247 | 0.4739 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0247 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0323 | 0.0789 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.052 | 0.1271 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0323 | 0.5 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0071 | 0.024 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0071 | 0.136 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0445 | 0.8552 |
Brugia malayi | hypothetical protein | 0.023 | 0.2253 | 0.7644 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0496 | 0.1684 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0491 | 0.1667 |
Brugia malayi | RNA binding protein | 0.0063 | 0.052 | 0.1765 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.052 | 1 |
Echinococcus granulosus | tumor protein p63 | 0.0408 | 0.4093 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0247 | 0.4739 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0247 | 0.0836 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.052 | 0.052 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.0491 | 0.9444 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0071 | 0.136 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.052 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0323 | 0.0323 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2473 | 0.8388 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0445 | 0.8552 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.052 | 0.1765 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.052 | 0.1765 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0247 | 0.0247 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.2832 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 0.4093 | 0.4093 |
Loa Loa (eye worm) | hypothetical protein | 0.0297 | 0.2948 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0071 | 0.024 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0323 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0445 | 0.1087 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0445 | 0.0445 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.023 | 0.2253 | 0.5505 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1365 | 0.4629 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0247 | 0.0836 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0071 | 0.136 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0445 | 0.151 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0445 | 0.8552 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0299 | 0.1015 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.052 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | 4.476 uM | PubChem BioAssay. Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 5.701 uM | PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.31 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.3753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.9953 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 21.3313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.